Knoa Pharma Names Former Viatris CEO Michael Goettler to Lead Firm
Michael Goettler takes the helm as President and CEO of Knoa Pharma starting July 6, stepping into a specialized role at a company founded just two months ago to combat the opioid crisis. His appointment marks a strategic move to stabilize the firm’s mission of balancing analgesic distribution with overdose prevention.